SCHEMBL20101093

SCHEMBL20101093

NNc1nc2cc(Cl)ncc2s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.58
MEN1 O00255 9/20 0.54
KMT2A Q03164 9/20 0.54
MAPT P10636 9/20 0.54
ALDH1A1 P00352 8/20 0.54
GAA P10253 6/20 0.54
LMNA P02545 5/20 0.54
KDM4E B2RXH2 5/20 0.54
RAB9A P51151 4/20 0.54
NPC1 O15118 3/20 0.54
ALOX12 P18054 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
HTT P42858 1/20 0.54
TDP1 Q9NUW8 5/20 0.46
PKM P14618 4/20 0.46
MAPK1 P28482 3/20 0.46
GFER P55789 1/20 0.46
POLB P06746 2/20 0.42
HPGD P15428 1/20 0.42
ENPP1 P22413 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30240959 0.77 ALDH1A1 (0.48) KMT2AMAPTALDH1A1GAALMNA
SCHEMBL19329204 0.77 ALDH1A1 (0.48) KMT2AMAPTALDH1A1GAALMNA
SCHEMBL20783923 0.76 KMT2A (0.41) IDO1MEN1KMT2AMAPTALDH1A1
SCHEMBL20101123 0.76 MEN1 (0.46) IDO1MEN1KMT2AMAPTALDH1A1
SCHEMBL2137684 0.74 IDO1 (1.00) IDO1MEN1KMT2AMAPTALDH1A1
SCHEMBL25604729 0.73 SMN1; SMN2 (0.55) KMT2AMAPTALDH1A1GAARAB9A
SCHEMBL31167917 0.71 LCK (0.51) RAB9AENPP1
SCHEMBL2116067 0.70 MEN1 (1.00) IDO1MEN1KMT2AMAPTALDH1A1
SCHEMBL20101017 0.69 NPC1 (0.48) IDO1MEN1KMT2AMAPTALDH1A1
SCHEMBL11831845 0.69 ALDH1A1 (0.58) IDO1MEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081612-A1 COMPOUNDS AND METHODS FOR TREATING CANCER ACTAVALON, INC. (US) 2018-05-03 WO disclosed